We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EDRY:NASDAQEuroDry Ltd. Analysis

Data as of 2026-03-30 - not real-time

$18.71

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: EuroDry trades around $18.71, sitting below its 20‑day SMA (~$19.71) but comfortably above the 50‑day (~$17.22) and 200‑day (~$13.11) averages, indicating a longer‑term bullish bias. The RSI hovers near 50 and the MACD histogram is negative, while price is near the calculated support of $17.02, suggesting limited downside. Volume is on the rise and the Fear & Greed index reads 68 (Greed), reflecting positive market sentiment.
Fundamental outlook: Revenue grew ~20% YoY to $52 M with healthy gross (36%) and operating (27%) margins, and the latest quarter posted a $3.2 M net profit after a prior loss, signaling an earnings turnaround. The balance sheet is leveraged (debt ≈ $103 M vs cash $20 M, debt‑to‑equity ~100%), yet valuation is compelling: forward PE of 5.9 versus industry ~28, price‑to‑book of 0.58, and a DCF fair value near $74 implying ~56% upside. High 30‑day volatility (~92%) and micro‑cap liquidity constraints add risk, but the upside potential and improving earnings make the stock attractive for investors willing to tolerate debt‑service and sector cyclicality.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Recent quarterly profit turnaround
  • Price near technical support with increasing volume
  • Significant upside implied by DCF valuation

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Need to reduce high debt levels
  • Sustained revenue growth in dry‑bulk market
  • Potential volatility from shipping cycle

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Deep discount to book value and low P/E multiples
  • Long‑term demand growth for bulk commodities
  • Fleet capacity positioned for post‑cycle recovery

Key Metrics & Analysis

Financial Health

Revenue Growth19.90%
Profit Margin-8.16%
P/E Ratio5.9
ROE-3.64%
ROA0.05%
Debt/Equity100.36
P/B Ratio0.6
Op. Cash Flow$12.8M
Free Cash Flow$9.9M
Industry P/E28.0

Technical Analysis

TrendBullish
RSI49.3
Support$17.02
Resistance$22.79
MA 20$19.71
MA 50$17.22
MA 200$13.11
MACDBearish
VolumeIncreasing
Fear & Greed Index68.36

Valuation

Fair Value$73.89
Target Price$29.33
Upside/Downside56.82%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.65
Volatility91.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.